The Tata Memorial Center (TMC) is an autonomous grant-in-aid institution administered under the under the Department of Atomic Energy, Government of India.

It has spearheaded the Evidence-based Medicine (EBM) movement in oncology in India, and prioritizes Multidisciplinary Team (MDT) management through disease-specific groups, to ensure quality patient care.

Importantly, with a mission centered on comprehensive compassionate cancer care for all, approximately 60% of patients receive free or highly subsidized treatments.

Administrative control of both TMH and CRI was then transferred to the Department of Atomic Energy (DAE) in 1962, and these two arms merged to form the ‘Tata Memorial Center' (TMC) in 1966, with a mandate for service, education and research in cancer.

It houses the Bone Marrow Transplant unit and the Proton Therapy Centre, amongst others, and has now expanded to a fully fledged clinical hospital.

It has conducted large randomized controlled trials focusing on the efficacy of simple low cost and effective technologies for early detection of breast and cervical cancers among women.

This has led to development of pragmatic evidence-based guidelines that have strengthened national cancer control policies in India and have been adopted by other low and middle income countries (LMICs).

[citation needed] Tata Memorial Hospital is a post-graduate teaching centre and is affiliated to the Homi Bhabha National University.